Drupal.behaviors.print = function(context) {window.print();window.close();}>
VitaPath Genetics Lands $6M Equity Investment
September 10, 2009
VitaPath Genetics Lands $6M Equity Investment
By a GenomeWeb staff reporter
The company will use the funds to develop its diagnostic for a common birth defect.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Genetic Test Firm VitaPath Raises $5M
August 22, 2012 / GenomeWeb Daily News
Alere to Market VitaPath Genetics' Spina Bifida Assay
August 11, 2011 / GenomeWeb Daily News
Empire Genomics Licenses Biomarker from Cornell to Develop Prostate Cancer Dx
May 22, 2013 / GenomeWeb Daily News
Cancer Genetics Inks Deal with MultiPlan for Access to Tests, Services
May 21, 2013 / GenomeWeb Daily News
NanoString Technologies Files to Go Public
May 20, 2013 / GenomeWeb Daily News